Skip to main content
SpringerLink
Log in

Potential usefulness of norfloxacin in the treatment of urinary tract infections

  • Introduction
  • Current Topic: Norfloxacin: Microbiology — Pharmacology — Clinical Evaluation
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ito, A., Hirai, K., Abe, Y., Suzue, S., Irikura, T., Inoue, M., Mitsuhashi, S.: In vitro activity of AM-715, a new nalidixic acid analogue. Antimicrobial Agents and Chemotherapy 1980, 17: 103–108.

    PubMed  Google Scholar 

  2. King, A., Warren, C., Shannon, K., Phillips, I.: In vitro antibacterial activity of norfloxacin (MK-0366). Antimicrobial Agents and Chemotherapy 1982, 21: 604–607.

    PubMed  Google Scholar 

  3. Neu, H. C., Labthavikul, P.: In vitro activity of norfloxacin, a quinoline-carboxylic acid, compared to that of beta-lactams, aminoglycosides, and trimethoprim. Antimicrobial Agents and Chemotherapy 1982, 22: 23–27.

    PubMed  Google Scholar 

  4. Norrby, S. R., Jonsson, M.: Antibacterial activity of norfloxacin. Antimicrobial Agents and Chemotherapy 1983, 23: 15–18.

    PubMed  Google Scholar 

  5. Haase, D., Urias, B., Harding, G., Ronald, A.: Comparative in vitro activity of norfloxacin against urinary tract phatogens. European Journal of Clinical Microbiology 1983, 2: 235–241.

    PubMed  Google Scholar 

  6. Shah, P. M., Ottrad, M., Stille, W.: In vitro activity of norfloxacin in DST agar and urine agar compared to that of cinoxacin acid and pipemidic acid. European Journal of Clinical Microbiology 1983, 2: 272–274.

    PubMed  Google Scholar 

  7. Hirai, K., Ito, A., Abe, Y., Suzue, S., Irikura, T., Inoue, M., Mitsuhashi, S.: Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections. Antimicrobial Agents and Chemotherapy 1981, 19: 188–189.

    PubMed  Google Scholar 

  8. Rylander, M., Norrby, S. R.: Norfloxacin: penetration into subcutaneous tissue cage fluid in rabbits and in vivo efficacy. Antimicrobial Agents and Chemotherapy 1983, 23 (in press).

  9. Murayama, S., Kirai, K., Ito, A., Abe, Y., Irikura, T.: Studies on absorption, distribution and excretion of AM-715 in animals by bioassay method. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 97–104.

    Google Scholar 

  10. Nagatsu, Y., Endo, K., Irikura, T.: Studies on the fate of14C-labelled AM-715. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 105–118.

    Google Scholar 

  11. Nagatsu, Y., Endo, K., Irikura, T.: Studies on the metabolism of14C-labelled AM-715. Chemotherapy (Tokyo) 1981, 29, Suppelement 4: 119–127.

    Google Scholar 

  12. Abiko, T., Ishihama, A., Ogawa, N., Uchida, H., Murayama, S., Hirai, K., Oomori, Y., Abe, Y., Irikura, T.: Phase I study on AM-715. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 136–145.

    Google Scholar 

  13. Eandi, M., Viano, I., Di Nola, F., Leone, L., Genazzani, E.: Pharmacokinetics of norfloxacin in healthy volunters, and patients with renal and hepatic damage. European Journal of Clinical Microbiology 1983, 2: 253–259.

    PubMed  Google Scholar 

  14. Ozaki, T., Uchida, H., Irikura, T.: Studies on metabolism of AM-715 in humans by highperformance liquid chromatography. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 128–135.

    Google Scholar 

  15. Saito, T., Yamad, Y., Arai, T.: Studies on AM-715: Biliary excretion, tissue concentrations in the liever and the gall bladder and clinical evaluation in the surgical field. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 631–638.

    Google Scholar 

  16. Matsumuto, K., Suziki, H., Tsuchihasi, K., Niyazaki, A., Shishido, H., Noguchi, Y., Watanabe, K.: Laboratory and clinical studies on AM-715. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 370–379.

    Google Scholar 

  17. Iswasawa, T.: Fundamental and clinical studies on AM-715 in the otorhinolaryngolic field. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 715–729.

    Google Scholar 

  18. Ueda, Y., Saito, A., Shimada, J., Ohmori, M., Shiba, K., Yamaji, T., Ihara, Y., Hohjo, T., Miyhara, T.: Clinical studies on AM-715. Chemotherapy (Tokyo) 1981, 29, Supplement 4: 202–219.

    Google Scholar 

  19. Giamarellou, H., Tsagarakis, J., Petrikkos, G., Daikos, G. K.: Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections. European Journal of Clinical Microbiology 1983, 2: 266–269.

    PubMed  Google Scholar 

  20. Guerra, J. G., Falconi, E., Palmino, J. C., Benarente, K., de Mayolo, E. A.: Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections. European Journal of Clinical Microbiology 1983, 2: 260–265.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, University of Umeå, Umeå Regional Hospital, S-90185, Umeå, Sweden

    S. Ragnar Norrby

Authors
  1. S. Ragnar Norrby
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Norrby, S.R. Potential usefulness of norfloxacin in the treatment of urinary tract infections. Eur. J. Clin. Microbiol. 2, 227–229 (1983). https://doi.org/10.1007/BF02029522

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02029522

Search

Navigation